> top > docs > PubMed:17919354 > annotations

PubMed:17919354 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-82 Sentence denotes Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer.
TextSentencer_T2 83-226 Sentence denotes Porphyria cutanea tarda (PCT) is sometimes precipitated or aggravated by increased exposure to estrogen, estrogen-like compounds, or tamoxifen.
TextSentencer_T3 227-350 Sentence denotes We report the case of a 37-year-old white woman who developed sporadic PCT after she took oral contraceptives for 10 years.
TextSentencer_T4 351-444 Sentence denotes She was heterozygous for the common H63D mutation of the hemochromatosis-associated HFE gene.
TextSentencer_T5 445-688 Sentence denotes The PCT responded partially to the cessation of oral contraceptives and to phlebotomy therapy to maintain low iron stores, but only remitted after she received anastrozole therapy for management of adenocarcinoma of the breast at age 59 years.
TextSentencer_T6 689-858 Sentence denotes The pertinence of HFE mutations, anastrozole and tamoxifen treatment, and chemotherapy to the development and management of PCT in women with breast cancer is discussed.
T1 0-82 Sentence denotes Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer.
T2 83-226 Sentence denotes Porphyria cutanea tarda (PCT) is sometimes precipitated or aggravated by increased exposure to estrogen, estrogen-like compounds, or tamoxifen.
T3 227-350 Sentence denotes We report the case of a 37-year-old white woman who developed sporadic PCT after she took oral contraceptives for 10 years.
T4 351-444 Sentence denotes She was heterozygous for the common H63D mutation of the hemochromatosis-associated HFE gene.
T5 445-688 Sentence denotes The PCT responded partially to the cessation of oral contraceptives and to phlebotomy therapy to maintain low iron stores, but only remitted after she received anastrozole therapy for management of adenocarcinoma of the breast at age 59 years.
T6 689-858 Sentence denotes The pertinence of HFE mutations, anastrozole and tamoxifen treatment, and chemotherapy to the development and management of PCT in women with breast cancer is discussed.

DisGeNET

Id Subject Object Predicate Lexical cue
T0 435-438 gene:3077 denotes HFE
T1 408-423 disease:C0018995 denotes hemochromatosis
T2 707-710 gene:3077 denotes HFE
T3 831-844 disease:C0678222 denotes breast cancer
T4 707-710 gene:3077 denotes HFE
T5 831-844 disease:C0006142 denotes breast cancer
R1 T0 T1 associated_with HFE,hemochromatosis
R2 T2 T3 associated_with HFE,breast cancer
R3 T4 T5 associated_with HFE,breast cancer

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 831-844 HP_0003002 denotes breast cancer
T2 831-844 HP_0100013 denotes breast cancer
T3 838-844 HP_0002664 denotes cancer

DisGeNET5_variant_disease

Id Subject Object Predicate Lexical cue
17919354-3#36#40#geners1799945 387-391 geners1799945 denotes H63D
17919354-3#57#72#diseaseC0018995 408-423 diseaseC0018995 denotes hemochromatosis
17919354-3#57#72#diseaseC3469186 408-423 diseaseC3469186 denotes hemochromatosis
36#40#geners179994557#72#diseaseC0018995 17919354-3#36#40#geners1799945 17919354-3#57#72#diseaseC0018995 associated_with H63D,hemochromatosis
36#40#geners179994557#72#diseaseC3469186 17919354-3#36#40#geners1799945 17919354-3#57#72#diseaseC3469186 associated_with H63D,hemochromatosis

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
17919354-3#84#87#gene3077 435-438 gene3077 denotes HFE
17919354-3#57#72#diseaseC0018995 408-423 diseaseC0018995 denotes hemochromatosis
17919354-3#57#72#diseaseC3469186 408-423 diseaseC3469186 denotes hemochromatosis
17919354-5#18#21#gene3077 707-710 gene3077 denotes HFE
17919354-5#18#21#gene3077 707-710 gene3077 denotes HFE
17919354-5#142#155#diseaseC0006142 831-844 diseaseC0006142 denotes breast cancer
17919354-5#142#155#diseaseC0678222 831-844 diseaseC0678222 denotes breast cancer
17919354-5#124#127#diseaseC0162566 813-816 diseaseC0162566 denotes PCT
84#87#gene307757#72#diseaseC0018995 17919354-3#84#87#gene3077 17919354-3#57#72#diseaseC0018995 associated_with HFE,hemochromatosis
84#87#gene307757#72#diseaseC3469186 17919354-3#84#87#gene3077 17919354-3#57#72#diseaseC3469186 associated_with HFE,hemochromatosis
18#21#gene3077142#155#diseaseC0006142 17919354-5#18#21#gene3077 17919354-5#142#155#diseaseC0006142 associated_with HFE,breast cancer
18#21#gene3077142#155#diseaseC0678222 17919354-5#18#21#gene3077 17919354-5#142#155#diseaseC0678222 associated_with HFE,breast cancer
18#21#gene3077124#127#diseaseC0162566 17919354-5#18#21#gene3077 17919354-5#124#127#diseaseC0162566 associated_with HFE,PCT
18#21#gene3077142#155#diseaseC0006142 17919354-5#18#21#gene3077 17919354-5#142#155#diseaseC0006142 associated_with HFE,breast cancer
18#21#gene3077142#155#diseaseC0678222 17919354-5#18#21#gene3077 17919354-5#142#155#diseaseC0678222 associated_with HFE,breast cancer
18#21#gene3077124#127#diseaseC0162566 17919354-5#18#21#gene3077 17919354-5#124#127#diseaseC0162566 associated_with HFE,PCT

PubCasesORDO

Id Subject Object Predicate Lexical cue
AB1 83-106 ORDO:101330 denotes Porphyria cutanea tarda
TI1 13-36 ORDO:101330 denotes porphyria cutanea tarda
AB2 298-301 ORDO:101330 denotes PCT
AB3 449-452 ORDO:101330 denotes PCT
AB4 813-816 ORDO:101330 denotes PCT

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 68-74 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 665-671 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 831-837 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast